Quantel Medical Launches IPL System for the Treatment of Dry Eye Disease


Quantel Medical today announced the launch of its C.STIM IPL system, based on intense pulsed light technology for the treatment of dry eye disease.

Dry eye is a huge public health problem affecting more than 700 million people worldwide and it is the most common pathology during ophthalmic visits. The treatment of dry eye is now a key issue in many specialties such as glaucoma, refractive and cataract surgeries, contact lenses and others.

The company pointed out in a press release that the IPL system addresses the root causes of dry eye: meibomian gland dysfunction, inflammation and Demodex, to stop the vicious cycle of dry eye.

According to Delphine Southon, Dry Eye Product Manager, C.STIM, the platform offers clinical efficiency and patient comfort.

C.STIM has been designed with the aim of combining cutting-edge technology with a sleek, robust and ergonomic design. The device incorporates the best technological features to guarantee efficiency, safety, ergonomics and offer a “plug and play” product that is easy to delegate.

“Building on Quantel Medical’s years of experience in intense pulsed light in dermatology, we have now developed an IPL device exclusively for ophthalmology, designed and manufactured by Lumibird Medical Group,” said Jean-Marc Gendre, CEO of Lumibird Medical.

Gendre said the product will provide a therapeutic solution for ophthalmologists to treat dry eye patients.

According to the press release, Quantel Medical provides ophthalmologists with therapeutic laser solutions to treat the four leading causes of blindness: glaucoma, cataracts, diabetic retinopathy and macular degeneration.

Lumibird Medical is the medical holding company of the Lumibird group, a company involved in the development of solid-state lasers for scientific and industrial use. It includes Quantel Medical (France and Poland) and Ellex (Australia, Japan and the United States), since July 2020, as well as Optotek Medical in Slovenia and Lumibird Medical Nordics (Sweden, Finland and Norway)

Source link

Comments are closed.